Management of FMR and TR: what do the guidelines say?

Back

HFA Premium Access

Management of FMR and TR: what do the guidelines say?

Session: Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?

Topic: Valvular Heart Disease

Speaker: Professor S. Anker (Berlin, DE)

Organised by Charité Berlin, supported with an educational grant by Edwards Lifesciences

Event: Heart Failure 2018

Congress Presentation

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

163 presentations

8 followers

4 more presentations in this session

Tricuspid regurgitation in 2018: what are the challenges?

Speaker: Doctor M. Enriquez-Sarano (Minneapolis, US)

Access

Update on treatment of tricuspid regurgitation.

Speaker: Professor U. Schaefer (Hamburg, DE)

Access

Is it time for a paradigm change?

Speaker: Professor F. Maisano (Milan, IT)

Access

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE) Professor W. Abraham (Columbus, US) Professor F. Maisano (Milan, IT) Professor U. Schaefer (Hamburg, DE) Doctor M. Enriquez-Sarano (Minneapolis, US) Professor P. Seferovic (Belgrade, RS)

Access

Access the full session

Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?

Speakers: Professor S. Anker, Doctor M. Enriquez-Sarano, Professor U. Schaefer, Professor F. Maisano, Professor S. Anker...

Access

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

Management of FMR and TR: what do the guidelines say?

About the speaker

Professor Stefan Anker

4 more presentations in this session

Tricuspid regurgitation in 2018: what are the challenges?

Update on treatment of tricuspid regurgitation.

Is it time for a paradigm change?

Panel discussion.

Access the full session

Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?

About the event

Heart Failure 2018

ESC 365 is supported by